KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Payables: 2010-2024

Historic Payables for Dynavax Technologies (DVAX) over the last 15 years, with Dec 2024 value amounting to $9.1 million.

  • Dynavax Technologies' Payables rose 520.98% to $44.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.1 million, marking a year-over-year increase of 418.29%. This contributed to the annual value of $9.1 million for FY2024, which is 72.76% up from last year.
  • As of FY2024, Dynavax Technologies' Payables stood at $9.1 million, which was up 72.76% from $5.2 million recorded in FY2023.
  • Over the past 5 years, Dynavax Technologies' Payables peaked at $9.1 million during FY2024, and registered a low of $2.6 million during FY2021.
  • For the 3-year period, Dynavax Technologies' Payables averaged around $5.8 million, with its median value being $5.2 million (2023).
  • Its Payables has fluctuated over the past 5 years, first tumbled by 64.30% in 2020, then skyrocketed by 72.76% in 2024.
  • Over the past 5 years, Dynavax Technologies' Payables (Yearly) stood at $3.3 million in 2020, then fell by 21.50% to $2.6 million in 2021, then grew by 23.50% to $3.2 million in 2022, then soared by 63.34% to $5.2 million in 2023, then spiked by 72.76% to $9.1 million in 2024.